Erich’s practice focuses on transactions involving technology and intellectual property, with an emphasis on the life science and software industries. He represents companies and investors in licensing deals, corporate partnerships, complex technology transactions, and a broad range of commercial matters.
Erich earned his J.D., cum laude, from Harvard Law School, where he was a member of the Journal of Law & Technology and served as a teaching assistant. He studied biology and chemistry at Davidson College, where he was elected to Phi Beta Kappa and received his B.S., magna cum laude.
Before law school, Erich worked as a scientist at the Duke Human Vaccine Institute, where he authored several publications on HIV pathogenesis and vaccine technology.
- American Bar Association
- North Carolina State Bar
- North Carolina Bar Association
- Wake County Bar Association
- Represented lead investor in multiple >$50,000,000 pharmaceutical product financing transactions.
- Represented digital therapeutics company in the negotiation of multiple complex partnerships for the development and commercialization of novel therapeutics.
- Represented global pharmaceutical company in strategic investments in early-stage biotechs.
- Represented publicly-traded biotechnology company in the negotiation and drafting of an in-license critical to their core program.
- Represented SaaS start-up in a bet-the-company deal with a global pharmaceutical corporation.